" class="no-js "lang="en-US"> Accelerate Diagnostics - Medtech Alert
Friday, March 31, 2023
Accelerate Diagnostics | Pharmtech Focus

Accelerate Diagnostics

About Accelerate Diagnostics

Accelerate Diagnostics

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1–2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.

Related Story

Accelerate Diagnostics Announces Commercialization in Europe of Its Accelerate Arc™ System Having Completed IVDR Registration

July 13 2022

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global […]